Federated Hermes, Inc. Novartis Ag Transaction History

Federated Hermes, Inc.

  • $41.2 Billion
  • Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Federated Hermes, Inc. holds 97,936 shares of NVS stock, worth $10.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
97,936
Previous 110,202 11.13%
Holding current value
$10.8 Million
Previous $10.7 Million 2.19%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$92.57 - $107.37 $1.14 Million - $1.32 Million
-12,266 Reduced 11.13%
97,936 $10.4 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $938,695 - $1.07 Million
-9,853 Reduced 8.21%
110,202 $10.7 Million
Q4 2023

Jan 31, 2024
SELL
$92.27 - $101.54 $341,029 - $375,291
-3,696 Reduced 2.99%
120,055 $12.1 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $278,032 - $308,556
-2,935 Reduced 2.32%
123,751 $12.6 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $1.5 Million - $1.7 Million
-16,220 Reduced 11.35%
126,686 $12.8 Million
Q1 2023

May 08, 2023
BUY
$80.03 - $92.81 $511,151 - $592,777
6,387 Added 4.68%
142,906 $13.1 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $1.76 Million - $2.16 Million
-23,358 Reduced 14.61%
136,519 $12.4 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $1.22 Million - $1.43 Million
16,398 Added 11.43%
159,877 $12.2 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $1.49 Million - $1.74 Million
-18,521 Reduced 11.43%
143,479 $12.1 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $5.2 Million - $5.88 Million
64,879 Added 66.8%
162,000 $14.2 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $1.63 Million - $1.8 Million
-20,445 Reduced 17.39%
97,121 $8.5 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $684,416 - $796,226
8,369 Added 7.66%
117,566 $9.62 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $1.6 Million - $1.76 Million
18,736 Added 20.71%
109,197 $9.96 Million
Q1 2021

May 13, 2021
SELL
$83.5 - $98.47 $132,932 - $156,764
-1,592 Reduced 1.73%
90,461 $7.73 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $85,174 - $103,023
-1,091 Reduced 1.17%
92,053 $8.69 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $231,963 - $256,984
-2,824 Reduced 2.94%
93,144 $8.1 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $2.2 Million - $2.48 Million
-27,206 Reduced 22.09%
95,968 $8.38 Million
Q1 2020

May 13, 2020
BUY
$70.67 - $99.01 $4.51 Million - $6.32 Million
63,830 Added 107.56%
123,174 $10.2 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $179,496 - $202,947
-2,128 Reduced 3.46%
59,344 $5.62 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $125,316 - $138,090
-1,465 Reduced 2.33%
61,472 $5.34 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $3.22 Million - $3.96 Million
-42,688 Reduced 40.41%
62,937 $5.75 Million
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $3.61 Million - $4.12 Million
-47,863 Reduced 31.18%
105,625 $10.2 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $200,870 - $223,668
-2,727 Reduced 1.75%
153,488 $11.8 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $2.21 Million - $2.56 Million
33,008 Added 26.79%
156,215 $13.5 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $318,708 - $360,197
-4,910 Reduced 3.83%
123,207 $9.31 Million
Q1 2018

May 09, 2018
SELL
$70.39 - $84.15 $8.27 Million - $9.89 Million
-117,559 Reduced 47.85%
128,117 $10.4 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $104,878 - $112,578
1,450 Added 0.59%
245,676 $0
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $18.1 Million - $18.9 Million
244,226
244,226 $21 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email